WisBusiness

MADISON, WISCONSIN— Quintessence Biosciences, Inc. announced today that the Phase I trial of its Investigational New Drug (IND), QBI-139, has begun enrolling patients. The Phase I Trial is taking place at the University of Wisconsin Paul P. Carbone Comprehensive Cancer Center (UWCCC) in Madison. QBI-139 is the first of the Company’s EVade™ Ribonuclease drug candidates to reach...

From WisBusiness.com ... -- The unemployment rate hit double digits in 12 Wisconsin cities in February, with Beloit again seeing the highest rate in the state. Beloit's 16.9 percent unemployment rate was up from 15.2 percent in January. The other cities with double-digit rates were Appleton, Fond du Lac, Green Bay, Janesville, Kenosha, Manitowoc, Milwaukee, Racine, Sheboygan, Wausau...

By Dustin Choy For WisBusiness.com A Milwaukee designer is trying to do his part to help out fledgling businesses in the down economy: he's created a Web site, newbusinessmilwaukee.com, that offers free advertising for start-ups in the Milwaukee area. The creator, Tom Story, launched the site about one month ago and currently features more than 30 new Milwaukee area businesses. “The Web site’s...